Table 1. Patients characteristics.
|
No lymphadenectomy (
N
=150)
|
Lymphadenectomy (
N
=158)
|
|||
|---|---|---|---|---|
| Characteristics | n | % | n | % |
| Median age (25–75th percentiles) | 52 (45–60) | 50 (44–58) | ||
| FIGO stage (primary surgery) | ||||
| I | 36 | 24.0 | 26 | 16.5 |
| IA | 8 | 6 | ||
| IB | 5 | 1 | ||
| IC | 23 | 19 | ||
| II | 17 | 11.5 | 25 | 15.8 |
| IIA | 4 | 4 | ||
| IIB | 7 | 14 | ||
| IIC | 6 | 7 | ||
| III | 90 | 60.0 | 99 | 62.6 |
| IIIA | 3 | 7 | ||
| IIIB | 11 | 7 | ||
| IIIC | 76 | 85 | ||
| IV | 6 | 4.0 | 8 | 5.1 |
| Missing data | 1 | 1.5 | 0 | 0 |
| Residual tumour at first surgery | ||||
| Absent | 57 | 38.0 | 59 | 37.3 |
| ⩽1 cm | 8 | 5.3 | 21 | 13.3 |
| >1 cm | 73 | 48.7 | 72 | 45.6 |
| Missing data | 12 | 8.0 | 6 | 3.8 |
| Tumour grade | ||||
| One well differentiated | 17 | 11.3 | 12 | 7.6 |
| Two moderately well differentiated | 36 | 24.0 | 35 | 22.2 |
| Three poorly differentiated | 87 | 58.0 | 105 | 66.5 |
| Missing data | 10 | 6.7 | 6 | 3.8 |
| Cell type | ||||
| Serous | 79 | 52.7 | 100 | 63.3 |
| Endometriod | 31 | 20.7 | 15 | 9.5 |
| Mucinous | 8 | 5.3 | 7 | 4.4 |
| Clear-cell | 8 | 5.3 | 13 | 8.2 |
| Undifferentiated | 8 | 5.3 | 15 | 9.5 |
| Other | 8 | 5.3 | 6 | 3.8 |
| Missing data | 8 | 5.3 | 2 | 1.3 |
| Residual tumour at II look surgery | ||||
| Absent | 118 | 78.7 | 123 | 77.8 |
| Surgically converted to absent | 22 | 14.7 | 26 | 16.4 |
| ⩽1 cm | 10 | 6.7 | 8 | 5.1 |
| Missing data | 0 | 0 | 1 | 0.6 |
Abbreviation: FIGO=Federation of Gynaecology and Obstetrics.